Claude Méric
Publications by Year
Research Areas
Cytomegalovirus and herpesvirus research, Herpesvirus Infections and Treatments, HIV Research and Treatment, Mosquito-borne diseases and control, Viral Infections and Outbreaks Research
Most-Cited Works
- → Implication of γδ T cells in the human immune response to cytomegalovirus(1999)325 cited
- → Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein(1989)252 cited
- → Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging(1986)192 cited
- → A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects(2001)146 cited
- → A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)(1995)142 cited
- → The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope(2012)139 cited
- → Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes(1988)134 cited
- → A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne)(1999)127 cited
- → It is Rous Sarcoma virus protein P12 and not P19 that binds tightly to Rous Sarcoma virus RNA(1984)79 cited
- → Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV‐Seronegative Adults(2002)78 cited